Richard F Kefford Selected Research

Richard F Kefford Research Topics

Disease

98	Melanoma (Melanoma, Malignant) 01/2021 - 03/2003
45	Neoplasms (Cancer) 11/2020 - 02/2003
13	Neoplasm Metastasis (Metastasis) 11/2018 - 07/2012
10	Disease Progression 12/2015 - 06/2007
6	Brain Neoplasms (Brain Tumor) 01/2021 - 05/2012
3	Nevus (Nevi) 11/2011 - 08/2009
3	Pancreatic Neoplasms (Pancreatic Cancer) 07/2007 - 10/2006
2	Uveal melanoma 11/2018 - 10/2006
2	Fever (Fevers) 10/2014 - 11/2012
2	Nervous System Neoplasms (Neoplasms, Nervous System) 07/2007 - 12/2006
1	Monosomy 11/2018
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 04/2016
1	Hemolysis 04/2016
1	Adenocarcinoma 04/2015
1	Tenosynovitis 01/2015
1	Arthritis (Polyarthritis) 01/2015
1	Sarcoma (Soft Tissue Sarcoma) 10/2014
1	Keratosis 10/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2014
1	Acneiform Eruptions 10/2014
1	Facial Paralysis (Facial Palsy) 04/2013
1	Carcinogenesis 12/2012
1	Neutropenia 11/2012

Drug/Important Bio-Agent (IBA)

22	dabrafenibIBA 01/2019 - 03/2012
16	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2017 - 07/2012
13	trametinibIBA 01/2020 - 11/2012
10	Pharmaceutical PreparationsIBA 01/2015 - 05/2012
9	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2012
9	VemurafenibIBA 12/2015 - 03/2012
9	Tumor Suppressor Protein p14ARF (p14ARF)IBA 02/2010 - 02/2003
8	Immune Checkpoint InhibitorsIBA 01/2020 - 08/2015
8	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2009
7	DNA (Deoxyribonucleic Acid)IBA 08/2020 - 03/2003
6	Phosphotransferases (Kinase)IBA 01/2020 - 12/2014
6	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2011 - 10/2008
5	Circulating Tumor DNAIBA 08/2020 - 01/2018
5	Mitogen-Activated Protein KinasesIBA 01/2020 - 07/2013
5	AntibodiesIBA 01/2018 - 07/2012
3	ParaffinIBA 01/2019 - 01/2013
3	Formaldehyde (Formol)FDA Link 01/2019 - 01/2013
3	NivolumabIBA 09/2017 - 04/2016
3	pembrolizumabIBA 09/2017 - 01/2015
3	Type 1 Melanocortin ReceptorIBA 09/2013 - 03/2003
2	Cell-Free Nucleic AcidsIBA 08/2020 - 09/2013
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2018
2	CytokinesIBA 01/2019 - 03/2014
2	IpilimumabIBA 01/2018 - 04/2016
2	InterferonsIBA 01/2018 - 03/2017
2	CateninsIBA 10/2017 - 01/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2016 - 03/2010
2	Biological ProductsIBA 12/2015 - 03/2009
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2013 - 11/2005
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 08/2009 - 07/2007
1	Histocompatibility Antigens Class IIBA 11/2020
1	AntigensIBA 11/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Dual Specificity Phosphatase 6IBA 01/2019
1	Peptide Initiation Factors (Initiation Factor)IBA 11/2018
1	RNA Splicing FactorsIBA 11/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	encorafenibIBA 09/2017
1	Blood Proteins (Serum Proteins)IBA 01/2017
1	Monoclonal AntibodiesIBA 04/2016
1	IsoantibodiesIBA 04/2016
1	tributyl phosphate (TBP)IBA 10/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2014
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2014
1	SteroidsIBA 10/2014
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2014
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2014
1	ChemokinesIBA 03/2014
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 07/2013
1	Imatinib Mesylate (Gleevec)FDA Link 07/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2013
1	nilotinib FDA Link 07/2013
1	Cadherins (E-Cadherin)IBA 05/2013
1	A-Form DNA (A-DNA)IBA 03/2013
1	thiamine triphosphorate (TTP)IBA 01/2013
1	Amylases FDA Link 11/2012
1	Lipase (Acid Lipase)FDA Link 11/2012
1	Proto-Oncogene Proteins B-rafIBA 07/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2012
1	Granzymes (Granzyme)IBA 03/2012
1	PLX 4720IBA 03/2012
1	Microphthalmia-Associated Transcription FactorIBA 11/2011
1	CI 22IBA 04/2011
1	Endothelin Receptor AntagonistsIBA 03/2010
1	Dacarbazine (DIC)FDA LinkGeneric 03/2010
1	Endothelins (Endothelin)IBA 03/2010

Therapy/Procedure

33	Therapeutics 01/2021 - 02/2005
9	Immunotherapy 11/2020 - 03/2010
4	Drug Therapy (Chemotherapy) 01/2021 - 06/2007
2	Aftercare (After-Treatment) 10/2014 - 03/2012
1	Radiotherapy 01/2021
1	Neoadjuvant Therapy 01/2019
1	Drug Tapering 10/2014
1	Precision Medicine 12/2012